AbbVie (ABBV) Debt to Equity (2012 - 2026)

AbbVie (ABBV) posted quarterly Debt to Equity of -$9.7 for Q1 2026, down 120.75% YoY from $46.71 in Q1 2025, and up 48.4% sequentially from -$18.79 in Q4 2025.

AbbVie (ABBV) Debt to Equity (2012 - 2026) Analysis & Trends

AbbVie has disclosed Debt to Equity across 15 years of filings, most recently posting -$9.7 for Q1 2026.

  • In Q1 2026, Debt to Equity fell 120.75% year-over-year to -$9.7; the TTM figure through Mar 2026 stood at -$9.7 (down 120.75% YoY), while the FY2025 annual figure was -$18.79, down 194.14% from the prior year.
  • Debt to Equity climbed to -$9.7 in Q1 2026, from -$18.79 in the prior quarter.
  • Over the last five years, Debt to Equity for ABBV reached as high as $46.71 in Q1 2025 and fell as low as -$470.72 in Q2 2025.
  • The 5-year median for Debt to Equity is $4.67 (2023), against an average of -$23.01.
  • The widest YoY moves for Debt to Equity: up 489.12% in 2025, down 4645.63% in 2025.
  • A 5-year view of Debt to Equity shows it stood at $3.66 in 2022, then jumped by 56.06% to $5.71 in 2023, then jumped by 249.45% to $19.96 in 2024, then sank by 194.14% to -$18.79 in 2025, then jumped by 48.4% to -$9.7 in 2026.
  • According to Business Quant data, Debt to Equity over the past three periods registered -$9.7, -$18.79, and -$24.58 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 1.39
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 0.68
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -9.70
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 1.07
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 6.24
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 0.94
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 0.72
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.70
Dec 31, 2025 -18.79
Sep 30, 2025 -24.58
Jun 30, 2025 -470.72
Mar 31, 2025 46.71
Dec 31, 2024 19.96
Sep 30, 2024 11.71
Jun 30, 2024 10.36
Mar 31, 2024 7.93
Dec 31, 2023 5.71
Sep 30, 2023 5.01
Jun 30, 2023 4.33
Mar 31, 2023 4.67
Dec 31, 2022 3.66
Sep 30, 2022 3.77
Jun 30, 2022 4.96
Mar 31, 2022 3.89
Dec 31, 2021 4.97
Sep 30, 2021 5.94
Jun 30, 2021 6.52